Award
NIH Reporter #3U01AI184132-03S1
Clinical and mechanistic studies defining optimal preparative approaches to infants with IL2RG/JAK3/RAG1/RAG2 SCID: a randomized trial of busulfan dosage
Recipient
Not Specified
Award Amount
$111,904.00
Ceiling
$111,904.00
Awarded
August 27, 2026
Identifier
3U01AI184132-03S1
Award for clinical and mechanistic studies to optimize preparative approaches for infants with SCID, funded by the National Institute of Allergy and Infectious Diseases.
Description
The project involves clinical and mechanistic studies on infants with SCID. The study aims to optimize preparative approaches for HCT in SCID patients. The project is funded by NIH and involves multiple investigators and organizations.